Growth Metrics

Edwards Lifesciences (EW) Long-Term Investments (2016 - 2026)

Edwards Lifesciences has reported Long-Term Investments over the past 17 years, most recently at $278.6 million for Q4 2025.

  • For Q4 2025, Long-Term Investments fell 9.52% year-over-year to $278.6 million; the TTM value through Dec 2025 reached $278.6 million, down 9.52%, while the annual FY2025 figure was $278.6 million, 9.52% down from the prior year.
  • Long-Term Investments for Q4 2025 was $278.6 million at Edwards Lifesciences, up from $274.7 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $1.8 billion in Q4 2021 and troughed at $274.7 million in Q3 2025.
  • A 5-year average of $822.2 million and a median of $753.4 million in 2021 define the central range for Long-Term Investments.
  • Biggest five-year swings in Long-Term Investments: surged 128.82% in 2021 and later tumbled 58.74% in 2024.
  • Year by year, Long-Term Investments stood at $1.8 billion in 2021, then plummeted by 32.45% to $1.2 billion in 2022, then plummeted by 52.87% to $583.9 million in 2023, then crashed by 47.27% to $307.9 million in 2024, then fell by 9.52% to $278.6 million in 2025.
  • Business Quant data shows Long-Term Investments for EW at $278.6 million in Q4 2025, $274.7 million in Q3 2025, and $298.5 million in Q2 2025.